Oncology

Mevion Delivers First-Ever FIT Compact Proton Therapy System to Stanford He

Azra AI Expands Capabilities of Its Trusted, Industry-Leading End-to-End On

Kiromic BioPharma Reports Tumor Volume Decrease in Two Patients Enrolled in

Quantum-Si Showcases Advances in Multiomics at the Festival of Genomics UK

ATCC Appoints Dr. Ruth Cheng as New President and Chief Executive Officer

Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Guardant Health, ConcertAI Collaborate to Form First Data-As-A-Service That

PanGIA Biotech Expands Leadership Team, Appoints Curtiss McNair as Vice Pre

Tempus Announces the National Launch of FDA-Approved xT CDx Test

Viz.ai to Collaborate With Guardant Health to Improve Lung Cancer Detection

Tempus One Introduces New GenAI Capabilities to Query Millions of Unstructu

CEL-SCI Reports Fiscal 2024 Results: Set to Commence Confirmatory Study Tha

Sutter Health and GE HealthCare enter strategic partnership to benefit pati

Quantum-Si Launches Platinum® Pro: The End-to-End Solution for Deeper Insi

ConcertAI Presents at 43rd Annual J.P. Morgan Healthcare Conference: 2024 R

Schrödinger Provides Update on Progress Across the Business and Outlines 2

N-Power Medicine Acquires Syapse to Expand Its Next-Generation Community-Ba

Oxford Cancer Analytics Raises USD$11M in Series A Funding to Transform Ear

Transcarent To Acquire Accolade

Tempus Announces a Collaboration With Genialis to Develop RNA-Based Biomark

Quantum-Si’s New Preprint Showcases Protein Barcoding as a Powerful Tool